pi_augtyro

Loading viewer...

report

Format: PDF report

This document provides prescribing information for AUGTYRO, a kinase inhibitor for treating ROS1-positive non-small cell lung cancer and NTRK gene fusion solid tumors.

Browse all reports →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Bristol Myers Squibb

View all →

infographic

presentation

Similar reports from other companies

Browse all →

report

Crane Company

report

VEON Holdings